Skip to main content
OpenTrials

Clinical trial condition

Advanced Renal Cell Carcinoma

Explore clinical trials studying Advanced Renal Cell Carcinoma. Study availability and eligibility vary by location and protocol.

51 public trials 12 recruiting studies
Refine in advanced search Browse all conditions

Advanced Renal Cell Carcinoma trial results

Active, not recruiting

Study of Nivolumab in Combination With 177Lu-girentuximab for Kidney Cancer

NCT05239533

Conditions
Adenocarcinoma, Advanced Renal Cell Carcinoma, Carcinoma, +16 more
Locations
  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Suffolk-Commack (Limited Protocol Activities) Commack, New York, United States
View Trial Details
Active, not recruiting

A Study to Evaluate MEDI5752 and Axitinib in Subjects With Advanced Renal Cell Carcinoma

NCT04522323

Conditions
Adenocarcinoma, Advanced Renal Cell Carcinoma, Carcinoma, +15 more
Locations
  • Research Site Washington D.C., District of Columbia, United States
  • Research Site Fort Myers, Florida, United States
  • Research Site St Louis, Missouri, United States
  • Research Site New York, United States
View all 20 locations
View Trial Details
Active, not recruiting

Efficacy and Safety of Fruquintinib in Combination With Sintilimab in Advanced Renal Cell Carcinoma (FRUSICA-2)

NCT05522231

Conditions
Advanced Renal Cell Carcinoma
Locations
  • Beijing Chao-Yang Hospital, Capital Medical University Beijing, China
  • Cancer Hospital Chinese Academy of Medical Sciences Beijing, China
  • Peking Union Medical College Hospital Beijing, China
  • Peking University First Hospital Beijing, China
View all 48 locations
View Trial Details
Completed

A Study of the Effectiveness of Cabozantinib in Combination With Nivolumab as First-line Treatment of Advanced Renal Cell Carcinoma (aRCC) in Adults

NCT05361434

Conditions
Advanced Renal Cell Carcinoma
Locations
  • CHU St Pierre & Brugmann Brussels, Belgium
  • Jessa Ziekenhuis Hasselt, Belgium
  • CHU Namur Mont-Godinne Yvoir, Belgium
  • Centre Hospitalier Universitaire (CHU) de Angers Angers, France
View all 66 locations
View Trial Details
Completed

Nivolumab Combined With Ipilimumab Versus Sunitinib in Previously Untreated Advanced or Metastatic Renal Cell Carcinoma (CheckMate 214)

NCT02231749

Conditions
Adenocarcinoma, Advanced Renal Cell Carcinoma, Carcinoma, +15 more
Locations
  • Local Institution - 0006 Duarte, California, United States
  • Local Institution - 0057 La Jolla, California, United States
  • Local Institution - 0044 Los Angeles, California, United States
  • Local Institution - 0035 Los Angeles, California, United States
View all 189 locations
View Trial Details
Completed

Genetic Analysis of Blood and Tissue Samples From Patients With Advanced Cancer, Moonshot Study

NCT03707574

Conditions
Adnexal Diseases, Advanced Malignant Neoplasm, Advanced Melanoma, +85 more
Locations
  • Holy Cross Hospital Fort Lauderdale, Florida, United States
  • Lewis Cancer and Research Pavilion at Saint Joseph's/Candler Savannah, Georgia, United States
  • Hawaii Cancer Care Inc - Waterfront Plaza Honolulu, Hawaii, United States
  • Island Urology Honolulu, Hawaii, United States
View all 144 locations
View Trial Details
Completed

Study of Front Line Therapy With Nivolumab and Salvage Nivolumab + Ipilimumab in Patients With Advanced Renal Cell Carcinoma

NCT03117309

Conditions
Advanced Renal Cell Carcinoma
Locations
  • Yale University, Yale Cancer Center New Haven, Connecticut, United States
  • Georgetown University Washington D.C., District of Columbia, United States
  • Winship Cancer Institute of Emory University Atlanta, Georgia, United States
  • Northwestern University Feinberg Schooll Of Medicine Chicago, Illinois, United States
View Trial Details

Related conditions